Urea-Loaded PLGA Microspheres as Chemotaxis Stimulants for Helicobacter pylori
Prasanth Shanmughan1, Pravin Subrahmaniyan1, Dhruv Bhatnagar2
1Artie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, Texas, USA.
Researchers developed Poly(lactic-co-glycolic acid) (PLGA) microbeads to study Helicobacter pylori chemotaxis. These beads effectively attract H. pylori cells using urea, offering potential for bacterial eradication strategies.
Area of Science:
- Microbiology
- Biophysics
- Biomaterials Science
Background:
- Helicobacter pylori exhibits chemotaxis towards chemoattractants like urea.
- The biophysical mechanisms underlying H. pylori chemotaxis remain poorly understood.
- Urea is produced by stomach epithelial cells, influencing H. pylori behavior.
Purpose of the Study:
- To develop and characterize Poly(lactic-co-glycolic acid) (PLGA) microbeads as point sources of urea.
- To investigate the chemotactic response of H. pylori to urea released from PLGA microbeads.
- To explore the potential of PLGA microbeads in H. pylori eradication strategies.
Main Methods:
- Urea was encapsulated in PLGA microbeads with an average diameter of <0.8 μm.
- Microscopy and Dynamic Light Scattering were used for particle characterization.
- Urea release kinetics were measured over 2 weeks at varying pH.
- A diffusion model predicted urea gradients.
- Single-bead, single-cell chemotaxis assays were performed.
Main Results:
- PLGA microbeads demonstrated stability and a net negative surface charge.
- Approximately 70% of encapsulated urea was released over 2 weeks, primarily within 24 hours.
- Urea release rate was largely unaffected by pH variations (2.0-7.0).
- H. pylori cells showed sustained chemotaxis towards the beads, even after initial urea release.
- Experimental results validated model predictions of chemotactic attraction.
Conclusions:
- PLGA microbeads serve as effective delivery vehicles for stimulating H. pylori chemotaxis.
- The study provides a novel method for investigating bacterial chemotaxis.
- This approach holds promise for developing new bacterial eradication strategies against H. pylori.
More Related Videos
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Chemotaxis and Direction of Cell Migration
Chemotaxis in E. coli
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
